
The video spotlights Oracle’s evolving narrative: beyond its legacy database business, the company is aggressively expanding its cloud infrastructure (OCI) and positioning itself as a genuine hyperscaler. The speaker highlights recent OCI growth north of 80%, dwarfing the roughly 30% growth rates reported by Microsoft Azure, AWS, and Google Cloud, and argues that Oracle should now be viewed as a "hyperscaler at scale." Key data points include the continued dominance of Oracle’s database franchise among Fortune 5000 firms, the rapid uptake of OCI, and a recent debt raise aimed at funding AI‑centric infrastructure worldwide. The discussion also underscores Oracle’s broader enterprise software portfolio—ERP, CRM, and the Cerner health‑care platform—providing multiple cash‑generating streams beyond cloud services. Notable remarks label Oracle as a "NeoCloud" and stress that analysts often focus narrowly on AI, overlooking the depth of its enterprise solutions. The speaker cautions that debt repayment will rely not only on AI partnerships, such as with OpenAI, but also on the extensive backlog across its traditional software and services lines. For investors, the implication is clear: Oracle’s growth story is multi‑dimensional. Evaluating the stock requires weighing its hyperscale cloud momentum against the stability of its longstanding software franchises and the strategic use of leverage to capture AI opportunities.

The post outlines a free method for extracting complete AI image prompts using Google Gemini. By uploading a screenshot, users receive detailed style, lighting, color, and composition data that can be fed into any generator such as Midjourney or DALL‑E....

Been using Claude Code for ages but decided to try Claude Cowork on MacOS desktop app & setup Claude Cowork project to organise/plan my new Subtack I created https://ai.georgeliu.com. So draft posts, image assets all generated within project & even...

More local AI testing with Google Gemma 4 26B-A4B via LM Studio desktop app and also via headless CLI and using Claude Code https://ai.georgeliu.com/p/running-google-gemma-4-locally-with 🤓

FamilyMart is expanding its Convenience Wear line with the launch of two Citizen‑co‑branded wristwatches priced at about $12 each, featuring the retailer’s signature colors and 10 ATM water resistance. The move follows a rapid growth trajectory for the brand, which posted roughly...

Updated my AI Image Creator skill to support both Claude Code & Claude Desktop & Claude Cowork. You can now ask Claude to generate images via Google Gemini 3.1 Image Flash (Google Nano Banana 2), Flux 2, Riverflow 2 Pro,...
Solarcycle opened a Georgia recycling plant that could strengthen solar panel recovery and recycled solar glass production. https://www.metalnomist.com/2026/04/solarcycle-georgia-recycling-plant.html
Researchers at the Wilmot Cancer Institute, University of Rochester, published a Nature paper showing that glutathione supplementation can rescue cancer cell survival and promote tumor growth under cystine‑deficient conditions. The finding challenges the long‑standing view of glutathione as a universally...
We tested three of the best screenless fitness trackers from Whoop, Polar and Amazfit https://t.co/H37VkvuRod
What I don’t understand about the DRAM narrative is this: if HBM are a completely different market than commodity DRAM, why should we expect the latter market to be tight forever? It doesn’t compute
Wake Forest School of Medicine has started a five‑year, $5.7 million NIH‑funded MORPH trial to evaluate a low‑impact “movement medicine” protocol for seniors with osteoarthritis. The remote program uses wearables, mobile apps and weekly video groups to encourage frequent, gentle activity...

Wall Street Journal: Startup Uses AI and OpenClaw to Automate Developers ... our secret weapon at @getjustpaid . https://t.co/K5Zx4gPVl2 https://t.co/TcLCMfkdMl
Really? Because my wheels spin like crazy on AI and now I can actually implement a lot of ideas I didn’t have time for before.
Semaglutide and tirzepatide have shown a 20% drop in major cardiovascular events, a 24% slowdown in kidney disease progression, and a 33% lower Alzheimer’s diagnosis rate. The FDA’s expanded Wegovy label and a wave of new brain‑health trials are turning...
Is NVIDIA creating an open standard for enterprise AI agents, or are they following AWS's old playbook, locking vendors into their infrastructure under the guise of open source? It seems vendors might be getting a taste of their own medicine....
On that test, Claude and Grok are currently more aligned with user expectations. Gemini remains powerful, but in this workflow it often behaves more like a search-grounded retrieval system than a direct source-checking system. https://t.co/OxLcghJU0n